The estimated Net Worth of Helen M Boudreau is at least $446 Mille dollars as of 15 May 2024. Ms. Boudreau owns over 6,629 units of Premier Inc stock worth over $314,753 and over the last 9 years she sold PINC stock worth over $131,586. In addition, she makes $0 as Independent Director at Premier Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Boudreau PINC stock SEC Form 4 insiders trading
Helen has made over 1 trades of the Premier Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently she sold 6,629 units of PINC stock worth $131,586 on 15 May 2024.
The largest trade she's ever made was selling 6,629 units of Premier Inc stock on 15 May 2024 worth over $131,586. On average, Helen trades about 414 units every 0 days since 2016. As of 15 May 2024 she still owns at least 16,067 units of Premier Inc stock.
You can see the complete history of Ms. Boudreau stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Helen Boudreau biography
Helen M. Boudreau has been appointed as Independent Director of the Company effective 6/1/2020. She served as the Chief Operating Officer of the Bill and Melinda Gates Medical Research Institute, a nonprofit medical research organization, from June 2018 to June 2019. Previously, she served as the Chief Financial Officer at each of Proteostasis Therapeutics, Inc., a NASDAQ-listed biopharmaceutical company, from July 2017 to June 2018, and FORMA Therapeutics, Inc., a privately-held biotechnology company, from October 2014 to June 2017. Her prior experience includes executive positions with Novartis Corporation and Pfizer, Inc. and leadership roles with Pepsico/Yum! Brands, Inc., McKinsey & Company, Inc. and Bank of America Corporation. Ms. Boudreau served on the Board of Directors and as Chair of the Audit Committee and member of the Compensation Committee for Proteostasis Therapeutics, Inc. from 2016 to 2017. She also provides services on the Boards of Directors of two private healthcare-related companies. She obtained a bachelor’s degree from the University of Maryland and a Master of Business Administration from the University of Virginia Darden Graduate School of Business.
How old is Helen Boudreau?
Helen Boudreau is 54, she's been the Independent Director of Premier Inc since 2020. There are 19 older and 5 younger executives at Premier Inc. The oldest executive at Premier Inc is Marvin O'Quinn, 67, who is the Director.
What's Helen Boudreau's mailing address?
Helen's mailing address filed with the SEC is C/O SHATTUCK LABS, INC., 500 W. 5TH STREET, SUITE 1200, AUSTIN, TX, 78701.
Insiders trading at Premier Inc
Over the last 11 years, insiders at Premier Inc have traded over $25,805,748 worth of Premier Inc stock and bought 58,600 units worth $1,642,100 . The most active insiders traders include Marc D Miller, Craig S. Mc Kasson e Michael J. Alkire. On average, Premier Inc executives and independent directors trade stock every 38 days with the average trade being worth of $320,590. The most recent stock trade was executed by Andy Brailo on 6 September 2024, trading 21,390 units of PINC stock currently worth $436,998.
What does Premier Inc do?
as a leading national healthcare solutions organization, premier, inc. collaborates with healthcare organizations to improve supply chain management, decrease healthcare costs, integrate data and improve the health of communities. as an industry leader, premier has created one of the most comprehensive database of actionable data, best practices and cost reduction strategies. we enable our members to collaborate easily and efficiently improve their quality outcomes, while reducing costs. by engaging members and revealing new opportunities, we empower our alliance to improve performance like no one else in healthcare can.
What does Premier Inc's logo look like?
Complete history of Ms. Boudreau stock trades at Cara Therapeutics Inc, Premier Inc, Proteostasis Therapeutics Inc e Shattuck Labs
Premier Inc executives and stock owners
Premier Inc executives and other stock owners filed with the SEC include:
-
Susan DeVore,
Chief Executive Officer, Director -
Michael Alkire,
President -
Susan Dodson DeVore,
Advisor -
Craig McKasson,
Chief Financial Officer, Chief Administrative Officer -
Michael J. Alkire,
Pres, CEO & Director -
Leigh Anderson,
President - Performance Services -
Craig Steven McKasson,
Chief Admin. Officer, CFO, Sr. VP & Treasurer -
David Klatsky,
General Counsel -
Leigh T. Anderson,
Pres of Performance Services -
David L. Klatsky J.D.,
Gen. Counsel -
David Alfred Hargraves,
Sr. VP of Supply Chain -
Richard Statuto,
Director -
Ellen Wolf,
Independent Director -
Stephen D'Arcy,
Independent Director -
David Langstaff,
Independent Director -
Jody Davids,
Independent Director -
Peter Fine,
Director -
Marc Miller,
Director -
William Downey,
Director -
Scott Reiner,
Director -
Marvin O'Quinn,
Director -
Terry Shaw,
Chairman of the Board -
Barclay Berdan,
Director -
Jim Storey,
Vice President - Investor Relations -
Helen Boudreau,
Independent Director -
John Bigalke,
Independent Director -
Kelli Price,
Senior Vice President - People -
David Hargraves,
Senior Vice President - Supply Chain -
Andy Brailo,
Chief Customer Officer -
Lindsay A. Powers,
Sr. VP of People -
Kaycee Kalpin,
Chief Marketing Officer -
Blair Childs,
Sr. VP of Public Affairs -
Angeline C. McCabe,
VP of Investor Relations -
Philip A Incarnati,
Director -
R. Wesley Champion,
Sr. VP Premier Perf. Partners -
Keith J. Figlioli,
Sr. VP Healthcare Information -
Eric J Bieber,
Director -
William E Mayer,
Director -
Jeffrey W. Lemkin,
General Counsel -
Durral R. Gilbert,
President of Supply Chain Svs -
Andy Brailo,
Chief Commercial Officer -
Kelly Rakowski,
Sr. VP Premier Perf. Partners -
Susan Wang,
Director -
Tomi S. Ryba,
Director -
Robert Issai,
Director -
Christine K. Cassel,
Director -
Charles E Hart,
Director -
D. Gentry Rose,
Controller -
Alan R. Yordy,
Director -
Keith B Pitts,
Director -
Lindsay A Powers,
Sr. VP of People -
Crystal Climer,
Chief Accounting Officer -
Andrea L. Frohning,
Chief Human Resource Officer